Clinical Experience in the Use of Inhaled Nitric Oxide in Infants with Pulmonary Hypertension
Inhaled nitric oxide (iNO) is a potent local vasodilator. Numerous case reports describe its efficacy in treating persistent pulmonary hypertension of the newborn (PPHN). This report describes experience at the authors' institution with iNO therapy in 10 consecutive infants with PPHN of a numbe...
Saved in:
| Main Authors: | Robert P Lemke, Jaques Belik, Niels G Giddins, Carlos A Fajardo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1996-01-01
|
| Series: | Canadian Respiratory Journal |
| Online Access: | http://dx.doi.org/10.1155/1996/424895 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Beyond the inhaled nitric oxide in persistent pulmonary hypertension of the newborn
by: Mei-Yin Lai, et al.
Published: (2018-02-01) -
INHALED NITRIC OXIDE: CLINICAL EFFECTS AND INFLUENCE ON THE PROFILE OF INFLAMMATORY MARKERS IN PATIENTS WITH IDIOPATHIC PULMONARY HYPERTENSION
by: T. V. Martynyuk, et al.
Published: (2015-12-01) -
Scoping review of initiation criteria for inhaled nitric oxide in preterm infants (born
by: Hidehiko Nakanishi, et al.
Published: (2024-12-01) -
Inhaled nitric oxide: are expectations justified?
by: I. A. Kozlov
Published: (2024-12-01) -
Inhaled nitric oxide as an independent intervention to lower the risk of bronchopulmonary dysplasia in preterm infants (< 33 weeks) with pulmonary hypertension within the initial 3 days of life
by: Tasnim Azad, et al.
Published: (2025-07-01)